Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis

Copyright © 2021 Elsevier Inc. All rights reserved..

Diagnostic stewardship interventions can decrease unnecessary antimicrobial therapy and microbiology laboratory resources and costs. This retrospective cross-sectional study evaluated factors associated with inappropriate initial cerebrospinal fluid (CSF) testing in patients with suspected community-acquired meningitis or encephalitis. In 250 patients, 202 (80.8%) and 48 (19.2%) were suspected meningitis and encephalitis, respectively. 207 (82.8%) patients had inappropriate and 43 (17.2%) appropriate testing. Any inappropriate CSF test was greatest in the immunocompromised (IC) group (n = 54, 91.5%), followed by non-IC (n = 109, 80.1%) and HIV (n = 44, 80%). Ordering performed on the general ward was associated with inappropriate CSF test orders (adjOR 2.81, 95% CI [1.08-7.34]). Laboratory fee costs associated with excessive testing was close to $300,000 per year. A stepwise algorithm defining empiric and add on tests according to CSF parameters and patient characteristics could improve CSF test ordering in patients with suspected meningitis or encephalitis.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:102

Enthalten in:

Diagnostic microbiology and infectious disease - 102(2022), 1 vom: 20. Jan., Seite 115571

Sprache:

Englisch

Beteiligte Personen:

Morrison, Austin R [VerfasserIn]
Jones, Mathew C [VerfasserIn]
Makowski, Charles T [VerfasserIn]
Samuel, Linoj P [VerfasserIn]
Ramadan, Ahmad R [VerfasserIn]
Alangaden, George J [VerfasserIn]
Davis, Susan L [VerfasserIn]
Kenney, Rachel M [VerfasserIn]

Links:

Volltext

Themen:

Anti-Infective Agents
Antimicrobial stewardship
Cerebrospinal fluid (CSF) testing
Diagnostic stewardship
Encephalitis
Journal Article
Meningitis

Anmerkungen:

Date Completed 20.01.2022

Date Revised 20.01.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.diagmicrobio.2021.115571

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM33306030X